CRMR SLA, CHU d'Angers, Angers, France.
CRC SLA, CHU de Saint-Etienne, Saint-Etienne, France.
Ann Med. 2024 Dec;56(1):2398199. doi: 10.1080/07853890.2024.2398199. Epub 2024 Sep 5.
The diagnosis of amyotrophic lateral sclerosis (ALS) is based on evidence of upper and lower motor neuron degeneration in the bulbar, cervical, thoracic, and lumbar regions in a patient with progressive motor weakness, in the absence of differential diagnosis. Despite these well-defined criteria, ALS can be difficult to diagnose, given the wide variety of clinical phenotypes. Indeed, the central or peripheral location of the disease varies with a spectrum ranging from predominantly central to exclusively peripheral, symptoms can be extensive or limited to the limbs, bulbar area or respiratory muscles, and the duration of the disease may range from a few months to several decades. In the absence of a specific test, the diagnostic strategy relies on clinical, electrophysiological, biological and radiological investigations to confirm the disease and exclude ALS mimics. The main challenge is to establish a diagnosis based on robust clinical and paraclinical evidence without delaying treatment initiation by increasing the number of additional tests. This approach requires a thorough knowledge of the phenotypes of ALS and its main differential diagnoses.
肌萎缩侧索硬化症(ALS)的诊断基于在没有鉴别诊断的情况下,患有进行性运动无力的患者的延髓、颈、胸和腰区的上下运动神经元退化的证据。尽管有这些明确的标准,但鉴于广泛的临床表型,ALS 的诊断可能很困难。事实上,疾病的中枢或外周位置随从中枢为主到完全外周的范围变化,症状可能广泛或仅限于四肢、延髓区或呼吸肌,疾病的持续时间可能从几个月到几十年不等。在没有特定测试的情况下,诊断策略依赖于临床、电生理、生物学和影像学检查来确认疾病并排除 ALS 的类似物。主要的挑战是在不通过增加额外测试的数量来延迟治疗开始的情况下,基于可靠的临床和临床前证据建立诊断。这种方法需要对 ALS 的表型及其主要鉴别诊断有透彻的了解。